Advertisement
New Zealand markets closed

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NZD/USD

    0.5895
    -0.0010 (-0.18%)
     

  • NZD/EUR

    0.5529
    -0.0016 (-0.28%)
     

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • OIL

    83.53
    +0.80 (+0.97%)
     

  • GOLD

    2,415.80
    +17.80 (+0.74%)
     

  • NASDAQ

    17,151.41
    -242.91 (-1.40%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • Dow Jones

    38,006.20
    +230.82 (+0.61%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • NZD/JPY

    91.0980
    -0.1560 (-0.17%)
     

Here's My Top Value Stock to Buy Right Now

Alexander Carchidi, The Motley Fool
·3-min read

InMode (NASDAQ: INMD) is proof that there isn't always a trade-off between stocks with great value and those with tremendous growth potential. This medical device maker has everything you'd expect from a value stock -- a low valuation, repeatable business model, and cost-sensitive management -- and it also has the strong revenue and earnings expansion of a monster growth stock. Let's analyze how and why InMode sports these positive features but is not as richly valued as a company like Tesla.

Continue reading